Steven Cohen Calliditas Therapeutics Ab Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$27.01 - $32.92 $2.78 Million - $3.38 Million	-102,748 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$23.34 - $36.65 $3.62 Million - $5.69 Million	-155,144 Reduced 60.16%	102,748 $3.45 Million
Q3 2020 Nov 16, 2020	SELL	$21.61 - $25.69 $4.15 Million - $4.94 Million	-192,108 Reduced 42.69%	257,892 $6.19 Million
Q2 2020 Aug 14, 2020	BUY	$19.17 - $23.2 $8.63 Million - $10.4 Million	450,000 New	450,000 $10.4 Million

871K

1.5K

32.4K

Ticker CALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,624,800
Market Cap $1.03B
Description
Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.